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1 Abstract
2 Increasing evidence links intestinal permeability (IP), a feature of the intestinal barrier (IB), to several 
3 pathological or dysfunctional conditions. Several host and environmental factors, including dietary 
4 factors, can affect the maintenance of normal IP. In this regard, food bioactives such as polyphenols 
5 have been proposed as potential IP modulators even if the mechanisms involved are not fully 
6 elucidated yet. The aim of the present paper is to provide a short overview of the main evidence from 
7 in vitro and in vivo studies supporting the role of polyphenols in modulating IP and briefly discuss 
8 future perspectives in this research area. 
9 Keywords: polyphenols, intestinal permeability; in vitro studies, animal studies, human studies
10 Abbreviations 
11 IP, intestinal permeability; IB, intestinal barrier; IME, intestinal microbial ecosystem;  TJ, tight 
12 junction; GJ, gap junction; AJ, adherent junction; JAM, junctional adhesion molecules; ZO, zonula 
13 occludens; MLCK, myosin light chain kinase; PKC, protein kinase C; MAPK, mitogen-activated 
14 protein kinase; TLR4, toll-like receptor 4; NAFLD, non-alcoholic fatty liver disease; MS, multiple 
15 sclerosis; CNS, central nervous system; TNF, tumor necrosis factor; MD, mediterranean diet; SCFAs, 
16 short chain fatty acids; PPs, polyphenols; NF- kB, nuclear factor-kB; Nrf-2, nuclear factor erythroid 
17 2–related factor 2; IL, interleukine; HO, oxigenase enzyme; SOD, superoxide dismutase; GPx, 
18 glutathione peroxidase; DNA, deoxyribonucleic acid; IKK, ikB-kinase; PI3K, phosphoinositide-3-
19 kinases; AMPK, AMP-activated protein kinase; TEER, transepithelial electrical resistance; INF-γ, 
20 interferon-γ; ERK, extracellular regulated kinase; MaPLE, Microbiome mAnipulation through 
21 Polyphenols for managing gut Leakiness in the Elderly.
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22 Introduction
23 Over the last ten years there has been significant research effort to investigate the central role of gut 
24 function and properties in the promotion of human health and/or the development of several 
25 pathological conditions. 
26 The intestine is the main organ involved in the absorption of nutrients and water and it is the largest 
27 area of contact with environmental factors. It contains a large number of specialized immune cells 
28 that can coordinate with defensive responses that prevent or counteract exposure of the host and its 
29 immune system to luminal antigens of different origins (e.g. microbial and dietary origin) 1.
30 The definition and specific ontology related to the gut as a complex anatomical and functional system 
31 has been widely debated. Bischoff et al 2 defined the intestinal barrier (IB) as a “functional entity 
32 separating the gut lumen from the inner host and consisting of mechanical elements (mucus, epithelial 
33 layer), humoral elements (defensines, IgA), immunological elements (lymphocytes and innate immune 
34 cells), muscular and neurological elements”. Differently, intestinal permeability (IP), which 
35 contributes to the regulation of solute and fluid exchange between the lumen and tissues, should refer 
36 to a key feature of IB that is measurable as a whole or at a given site (e.g. evaluating specific 
37 molecules/factors flux rates). IP evaluation can be used to address a normal/stable or 
38 disturbed/compromised permeability related with IB function 2. In this context, it is fundamental to 
39 underline that IB integrity and functionality can be affected also by the characteristics of intestinal 
40 microbial ecosystem and mucosal immune system. 
41 From an anatomical point of view, a well-organized monolayer of epithelial cells is required to form 
42 a selective permeability system mainly controlled by the transcellular and the paracellular pathways 
43 3. 
44 While the absorption and/or transport of nutrients (i.e. sugars, amino acids, vitamins, fatty acids, 
45 minerals) occur through specific transporters or membrane channels (transcellular path) 3, a complex 
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46 system of junctions crucial for the transport between adjacent cells (i.e. tight junction (TJ), gap 
47 junctions (GJ), adherent junctions (AJ), and desmosomes)  constitute  the paracellular path 4. 
48 TJs have composite molecular structure consisting of multiple protein complexes (with more than 50 
49 proteins identified) that include a series of transmembrane tetra-span proteins, named occludin, 
50 claudins and tricellulin, able to develop fibrils crossing the membranes and creating a connection with 
51 adjacent cells proteins. In addition, single span transmembrane proteins are included and are mostly 
52 represented by junctional adhesion molecules (JAM, belonging to the immunoglobulin superfamily). 
53 The claudin proteins are considered to be the structural pillar of TJ 5. Specifically, TJ sealing, 
54 fundamental to avoid paracellular permeability is provided by claudin-1, -3, -4, -5, and -8, while 
55 claudin- 2 can form charge-selective pores. Less information is available for the specific activities of 
56 claudins-7, -12, -15 and occludin 6. 
57 The transmembrane proteins strictly interact with the intracellular scaffold proteins such as zonula 
58 occludens (ZO-1, ZO-2, ZO-3) and cingulin tight-fitting the actin cytoskeleton. In particular, 
59 increased paracellular permeability is activated by perijunctional actomyosin ring contraction induced 
60 by myosin light chain kinase (MLCK).  In addition, other signalling proteins, including protein kinase 
61 C (PKC) and mitogen-activated protein kinases (MAPK) together with phosphorylation are involved 
62 in the regulation pathways of assembly, disassembly, and maintenance of TJ specific properties 7.  
63 Finally, adherent junctions, together with desmosomes and gap junctions located beneath the TJ are 
64 involved in the cell-to-cell adhesion and intracellular signalling but seem not to contribute to 
65 paracellular permeability 8.  
66 By considering the complex interplay of functions and activities of TJ proteins and signals regulating 
67 the fluxes/exchanges of molecules between the lumen and the environment, it is clear that TJ barrier 
68 integrity is essential for human health and metabolic homeostasis.  
69 In fact, an impairment or defect in IB function can lead to modest (i.e. sub-clinical) but chronic 
70 immune system activation that might contribute to the pathogenesis of intestinal diseases such as 
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71 inflammatory bowel disease 4, celiac disease 9, intestinal bowel syndrome 10 up to colon cancer 11. In 
72 addition, recent research showed a possible correlation of IB dysfunction with several clinical 
73 conditions such as metabolic syndrome, obesity, Non-alcoholic Fatty Liver Disease (NAFLD) 12, 
74 diabetes 13 , inflammatory joint diseases 14 but also neurological conditions, such as major depression 
75 and degenerative disorders such as Parkinson’s disease 15 and multiple sclerosis (MS), involving the 
76 central nervous system (CNS) 16.
77 It is noteworthy that emerging experimental evidence suggests that an alteration of IB function and/or 
78 increased IP can actually occur also during aging, thus, potentially representing a further mechanism 
79 underpinning the activation of the low-grade systemic inflammation process (also named 
80 inflammaging) identified in older subjects 17. The alterations can take place at different levels of the 
81 intestinal barrier: for example, induced by impairment of the epithelium (physical barrier) and/or of 
82 the immune cells/function, or by an alteration of the chemical barrier consisting in the thick mucus 
83 layer able to reduce the passage of bacteria through the epithelium (i.e. mucin secretion) or due to an 
84 inefficient/inadequate microbial barrier (represented by the commensal “protective” bacteria). In this 
85 regard, it has been demonstrated that age-associated microbial dysbiosis can increase gut microbiota 
86 lipopolysaccharide (LPS) production, promote IP with increased risk of systemic endotoxemia and 
87 inflammation. In particular, bacteria LPS has been demonstrated to activate nuclear factor kappa b 
88 (NF-kB) and mitogen-activated protein kinase (MAPK) by triggering the toll-like receptor 4 (TLR4) 
89 inflammatory cascade in immune cells (e.g. macrophages, monocytes)18. 
90 In addition, dysbiosis is not only an age-associated characteristic but it can be found in different 
91 clinical conditions associated with inflammation (e.g. obesity, diabetes, NAFLD).
92 Thus, intestinal microbiota can be considered a critical regulator of the IP. Gut microorganisms may 
93 act directly on IP by affecting tight junction properties and activities and indirectly by modulating 
94 inflammation, which is a well-recognized factor promoting IP impairment 19. Consequently, the 
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95 manipulation of the complex intestinal microbial ecosystem  has been proposed as a novel strategy to 
96 restore IP 2.
97
98 Diet and IP
99 An adequate nutritional status is fundamental to maintain normal IB function (being able to affect all 
100 the components of IB) and accordingly, malnutrition is associated with increased IP 20. For example, 
101 Guerriero et al 21 showed that a depletion of glutamine, tryptophan and zinc could lead to increased 
102 IP.
103 Overall, it has been demonstrated that dietary patterns are a dominant factor in shaping the intestinal 
104 microbiota 22. Hence, strategies to modify the relative abundance of specific bacterial groups by 
105 means of dietary interventions has been proposed with the aim also to modulate the concentrations of 
106 microbial metabolites in the gut affecting inflammation 23.
107 It has been demonstrated that the Western diet, characterized by high-energy and high-fat intake or 
108 high fructose consumption, can alter IP by affecting the gut microbiota composition 21. In addition, 
109 this dietary pattern often involves the consumption of food components like specific fatty acids, 
110 alcohol, additives, gliadin, chitosan and food processing methods that are known to alter IB physical 
111 structure homeostasis and/or commensal microbial homeostasis. On the other hand, a healthy dietary 
112 pattern, such as the Mediterranean diet (MD) rich in fruit, vegetables, legumes and unrefined cereals 
113 has been suggested to positively affect IP and related conditions 21. This may be related to an increased 
114 production of short chain fatty acids (SCFAs) including acetate, propionate, butyrate and valerate2 by 
115 gut commensal bacteria following fiber degradation provided by MD dietary pattern. These 
116 metabolites have been suggested to play an important role as substrate for a functional colonic 
117 epithelium and the maintenance of the intestinal barrier. For example, butyrate showed to affect tight 
118 junction integrity but also inhibit TNF-α release and inflammation 23. In addition, butyrate has shown 
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119 to increase expression of claudin-1 and Zonula Occludens-1 (ZO-1), to reverse the aberrant 
120 expression of ZO-1 and decrease LPS translocation leading to inhibition of macrophage activation 
121 and pro-inflammatory cytokine production24.  Moreover, plant based dietary patterns including MD 
122 are also commonly abundant of bioactive compounds such as polyphenols that have been recently on 
123 the spotlight of research for their potential modulatory properties with respect to IP 25. 
124 Rationale for polyphenols contribution to a protective dietary pattern in the context of IP
125 Polyphenols (PPs) are secondary metabolites of plants, widely distributed in fruits, vegetables and 
126 plant-derived foods. A diet rich in fruits, vegetables and plant-based  beverages has been estimated 
127 to provide about 1 g of polyphenols/day 26, with significant variations depending also on the extent 
128 of consumption of beverages rich in polyphenols (tea, wine, coffee, fruit juices). The basic monomer 
129 in polyphenols is the phenolic ring. Phenols can be mainly classified into phenolic acids 
130 (hydroxycinnamic and hydroxybenzoic acids), flavonoids (flavons, flavanones, flavanols, flavonols, 
131 isoflavones and anthocyanidins), stilbenes (i.e. resveratrol) and lignans. PPs are recognized to be 
132 poorly bioavailable, rapidly absorbed and extensively metabolized by gut microbiota 27. Additional 
133 biotransformation can occur in liver and kidney through methylation, glucuronidation and sulfation 
134 reactions of phenolic hydroxyl groups 28 or these reasons, the concentration of the native compounds 
135 in the blood is low compared to their metabolic derivates (from nanomoles up to micromoles per 
136 liter). 
137 PPs and their metabolites are widely studied for their numerous biological activities, including 
138 antimicrobial, antiproliferative, antioxidant and anti-inflammatory function 29. These effects are 
139 exerted both at intestinal and systemic levels. In particular, PPs may exert their effects by down 
140 regulating inflammatory genes (i.e. nuclear factor-kB, NF-kB) and up-regulating cytoprotective and 
141 antioxidant genes (i.e. nuclear factor erythroid 2–related factor 2, Nrf-2). This modulation may bring 
142 to a reduction of cytokines production (e.g., IL-8, IL-1β, and TNF-α) and boost the bodies' own 
143 antioxidant status (HO-1, SOD, and GPx) 30. Furthermore, recent reviews 31,32 have shown that PPs 
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144 may affect, either in a positive or negative way, pattern recognition receptors such as Toll-like 
145 receptors and nucleotide-binding oligomerization domain proteins, whose activation in epithelial 
146 cells may lead to intestinal inflammation. Moreover, PPs seem to be involved in the regulation of 
147 epigenetic factors through interaction with the enzymes responsible for DNA methylation 
148 and acetylation by reducing intestinal inflammation 32.
149 Several studies documented the effects of PPs in the modulation of intestinal microbial ecosystem. 
150 However, the mechanisms by which these compounds modulate the gut microbiota remain unclear. 
151 Some studies report that the interaction between PPs and microbiota may involve interference with 
152 enzymatic expression and activity, and modulation of specific pathways related to anti-oxidant and 
153 anti-inflammatory activity 33. In addition, PPs has been proposed to exert a prebiotic effect potentially 
154 inhibiting the pathogenic bacteria and stimulating the growth of beneficial microbes 34–36. In fact, the 
155 microbiota can extensively metabolize PPs in numerous derivatives that could affect not only the 
156 composition of microbiota but also specific signalling pathways 33.   Another important aspect regards 
157 the possible involvement of PPs in the metabolism of colonic products, such as short chain fatty acids 
158 (SCFA), sterols (cholesterol and bile acids), and microbial products of non-absorbed proteins which 
159 may directly or indirectly counteract or suppress pro-oxidant and/or pro-inflammatory responses with 
160 an overall improvement of gut health 37. 
161 To unravel the complex scenario related with PP-microbiota interaction in vivo, a combination of 
162 metabolomic, microbiome and metagenomic approaches are strongly demanded 33. 
163 Finally, in the last few decades, specific research has been devoted to the evaluation of PPs as 
164 promising protective factors and regulators of the epithelial homeostasis and intestinal barrier 
165 function. In particular, a direct/indirect effect of regulation of tight junction proteins has been 
166 investigated. 
167 Mechanisms of polyphenols regulation of IP
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168 At present, the exact mechanisms linking PPs with intestinal epithelial barrier function have not been 
169 established yet (Figure 1). Some studies hypothesized a direct/indirect involvement of nuclear factor-
170 κB (NF-κB) signalling in the onset of IP. This pathway is recognized as one of the most important 
171 mediators of the inflammation; cytokines and interleukins have shown to activate NF-κB and impair 
172 the epithelial barrier function by tight junction disassembly. Conversely, PPs have documented to 
173 block NF-κB activation by inhibiting IKK (kinase) phosphorylation and/or preventing proteasomal 
174 degradation of IκB 38.      
175 Other important factors potentially involved in increasing IP are the multiple protein kinases such as 
176 mitogen-activated protein kinases (MAPK), phosphoinositide-3-kinases (PI3K)/Akt, protein kinase 
177 C (PKC), tyrosine kinases, myosin light chain kinase (MLCK) and AMP-activated protein kinase 
178 (AMPK). Most of them are regulators of fundamental biological processes in epithelial cells, 
179 including barrier function, primarily through regulating TJ expression. Some PPs (e.g. quercetin, 
180 curcumin, epigallocathechin3-gallate, myricetine) have shown to improve epithelial barrier function 
181 through the inhibition of different kinases (PKC and MLCK) involved in phosphorylation of target 
182 proteins controlling IP 3,30,39.   
183 In order to ascertain the availability of data supporting the role of PPs on IP, a literature search has 
184 been performed using the following terms “intestinal permeability” OR “intestinal barrier” AND 
185 “polyphenols” OR “bioactives” OR “phenolics” as keywords in PubMED. The use of the word 
186 “polyphenols” as specific keyword consistently reduced the number of results. On the contrary, a 
187 more appropriate search with single PP subclasses AND “intestinal permeability” provided a larger 
188 number of in vitro and animal studies mainly summarized in Tables (1-2) and an apparent lack of 
189 human intervention studies.
190
191 In vitro studies
192 The main lines of evidence on the in vitro effects of PPs in the modulation of the potential mediators 
193 and regulatory pathways involved in the IP are reported in Table 1. Most of the studies are performed 
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194 on Caco-2 cell line 38,40–58, as a model of the intestinal barrier, followed by T84, HT29/B6 cells 
195 (colonic adenocarcinoma cell line) 59–63, IPEC-J2 cells (intestinal porcine enterocytes) and ECV304 
196 cells (human endothelial cell line) 64,65. The main evidence of protection are available for berberine, 
197 quercetin and catechin tested in a range of concentration between 10 and 200 μM (from physiological 
198 to pharmacological concentrations). Other PPs tested included genistein, anthocyanins, resveratrol, 
199 theaflavin and mix of PPs. Most the studies have shown an increase in transepithelial electrical 
200 resistance (TEER) across a cellular monolayer confirming the integrity and functional permeability of 
201 the membranes 38,43–49,53–55,57,58,62,65,66. In addition, most the PPs tested have shown to increase the 
202 expression and/or production of numerous TJ proteins including zonula occludens (ZO)-1, occludin, 
203 and the family of claudins whose alteration may result in increased paracellular permeability 
204 41,42,44,53,55–57,63,65. Finally, some studies have reported the capacity of PP to counteract inflammatory 
205 process induced by TNF-α and IFN-γ down-regulating the expression of several interleukins such as 
206 IL-8 and IL-6 48,67.
207
208 Animal studies
209 In Table 2 are reported the effects of PPs and PP-rich extracts in the modulation of IP in  animal 
210 models 44,49,67–74. Most of the studies were performed in healthy rat models  (i.e. Wistar rats, Sprague-
211 Dawley rats) and IP was induced by stimuli such high fat diets, mannitol, inflammatory cytokines, or 
212 chemicals 44,72,74. Two studies used mice with IL-10 deficiency in order to test the effect on IP 69,70. 
213 The main PPs used were obtained from grape seed extracts (1% GSE; g GSE per g dry food weight) 
214 69,70 and grape seed proanthocyanidin extracts (5-50 mg/kg) 74. Other studies included berberine (200 
215 mg/kg) 68, (-)-epicatechin (2-20 mg/kg) 49  and epigallocatechin-3-gallate (about 3 mg/ml) 73. Some 
216 studies were performed by testing anthocyanins-rich raspberry extract, polyphenol-rich propolis 
217 extract, and oregano essential oil 44,72. The doses administered ranged from nearly physiological 
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218 (epicatechin) up to supra- physiological (i.e. berberine). The duration of the intervention varied from 
219 few days (3-10 days) up to several weeks (15-16 weeks). 
220 On the whole, the results obtained support an improvement of IP following the intervention with PPs 
221 and PP-rich extracts. In particular, the studies showed the capacity of PPs to up-regulate some 
222 important genes such as AMPK and ERK and down-regulate NF-kB as pathways involved in the 
223 inflammation process. In line with the observations reported in the in vitro studies, the compounds 
224 tested have shown to increase the expression of zonula occludens (ZO)-1, occludin, and several 
225 claudins involved in the functioning of tight junctions. 
226 Human studies
227 The number of human intervention studies with IP as primary or secondary outcome increased in the 
228 last years as also documented by the number of trials made available and reported in public registers 
229 (i.e. ISRCTN, ClinicalTrial.gov).
230 Most of these studies were performed, or are ongoing, by using probiotics, prebiotic fibers, dietary 
231 supplements, and sugars. Only 4 studies seem to have explored the potential beneficial effects of 
232 PPs/PP-rich foods on IP in humans (Table 3) 75–78. The studies differ in terms of population 
233 (overweight/obese, cyclists, older subjects), foods administered (green tea, flavonoid-rich beverage, 
234 mix of PP-rich foods), dose of bioactives (650 mg of flavonoids, 750 mg of PPs), duration of 
235 intervention (from 2 weeks up to 8 weeks), marker of IP selected (endotoxin, lactulose:mannitol ratio, 
236 zonulin levels). The trials are still ongoing, and the results will be useful to increase understanding 
237 on the actual role of PPs and PP-rich foods in humans where a large number of factors can interact 
238 affecting IP. For example, it is well recognized that PPs are poorly bioavailable and are 
239 biotransformed by gut microbiota into metabolites that can be absorbed in the colon. At the same 
240 time, PPs may modulate the composition of the gut microbial community shaping towards a 
241 protective symbionts and reducing pathobionts. The complex and not fully elucidated two way 
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242 interaction between PPs and gut microbiota is postulated to play a potential direct/indirect role on IP 
243 regulation.
244 In this context, the MaPLE project (Microbiome mAnipulation through Polyphenols for managing 
245 gut Leakiness in the Elderly) has been developed with the aim to test the hypothesis that changing 
246 the diet of older subjects with established enhanced IP by increasing their PPs consumption can alter 
247 IME in a way that is beneficial for IB function, resulting in reduced IP and decreased translocation 
248 of inflammogenic bacterial factors from the digestive tract into the bloodstream 78. To test this 
249 hypothesis, a multidisciplinary approach has been used (i) to evaluate the impact of a PP-rich dietary 
250 pattern on IB, IP and IME in a target group of older subjects; and (ii) to investigate the possible 
251 mechanisms involved in the PP-microbiota-IP interactions through in vitro and animal models.
252 Findings obtained from our and other studies will be “pivotal” for the development of new and 
253 advanced hypothesis and experimental approaches in this complex area of research.  
254
255 Some considerations on IP assessments in different contexts
256 IP can be evaluated through numerous methodologies and consequently data obtained can differ 
257 among studies. The techniques vary depending on the setting (in vitro, ex-vivo or in vivo models), 
258 the models (cells, animals, and humans), the markers (i.e. ions, macromolecules, bacteria and 
259 bacterial products) but also the compartments (i.e. tissues, blood, urines). The measurement of IP can 
260 be performed through ex vivo and in vivo approaches 79. An example of ex vivo approach includes 
261 the use of an Ussing chamber able to measure the transport of ions and molecules (i.e. nutrients, 
262 drugs) across various epithelial tissues by using fresh intestinal tissue. In vivo, the assessment of IP 
263 can be performed through permeability assays (i.e. evaluation of ratio lactulose/mannitol, sucralose, 
264 sucrose, polyethylene glycols or 52Cr-EDTA in urines), analysis of bacterial related markers (i.e. 
265 endotoxin test, EndoCAb, D-lactate, butyrate production), markers of epithelial damage (i.e. citrullin, 
266 fatty acid binding protein, cludin-3), and/or other related markers (i.e. faecal calprotectin). Finally, 
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267 histological approaches measuring for example Globet cell analysis, shedding of epithelium or Paneth 
268 cell loss, can be performed 2. 
269 On the whole, based on revised literature, it can be assumed that current in vitro permeability models 
270 are still far from reflecting an in vivo situation. This limits the relevance of data obtained within cell 
271 culture and the possibility to transfer the results to humans. In fact, the comparison between in vitro 
272 and in vivo permeability data is difficult and dependent on numerous factors, including the type of 
273 cells used, the molecule under study, the transport route evaluated and the method used for the 
274 assessment of intestinal barrier function and permeability (i.e. mainly TEER and biomarkers of 
275 epithelial integrity) which can significantly affect the results obtained making it difficult to identify 
276 the best approach.
277 A novel biomarker of IP in vivo is zonulin, a protein secreted by enterocytes but also from other type 
278 of cells (i.e. epithelial cells), known to be a  physiological modulator and thus to control IP reversibly 
279 via  intercellular TJs 80. Increased zonulin serum levels have been observed in many gut-related 
280 diseases and emerging evidence suggests an increased zonulin level in specific subjects (e.g. older 
281 persons) 81 and in different diseases or condition (e.g. diabetes, obesity) 82,83. The reliability and 
282 accuracy of the different markers to assess IP is clearly a fundamental part of the recent discussion 
283 and a hot topic considering the increasing demand for non-invasive diagnosis tools 84. In this regard, 
284 it seems highly recommendable the concurrent evaluation of different markers of IP to improve 
285 reliability of findings on intestinal barrier function.
286
287 Conclusion and future perspectives
288 There is increasing demand for non-invasive strategies able to modulate critical regulatory functions 
289 for human health such as IP, which can play a role in the pathogenesis of intestinal and systemic 
290 diseases. The improvement or manipulation of the diet, for example increasing or reducing specific 
291 nutrients and/or including food bioactives such as PPs is recognised as a potential powerful tool to be 
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292 explored also in the context of IP. From data available PPs activity seems to be plausibly a 
293 consequence of multiple mechanisms which may also depend on the type and amount of compounds 
294 considered. The results from in vitro studies have shown the capacity of PPs to increase the expression 
295 and/or production of numerous TJ proteins and to reduce the release of several interleukins/cytokines. 
296 These results are partially in line with the findings obtained in the animal models showing the capacity 
297 of PPs to up-regulate/down-regulate some important genes involved in the inflammatory process. 
298 Regarding human studies, recent literature suggests that PPs may modulate IP through a number of 
299 direct and indirect effects including the impact on intestinal ecosystem and immune system. This type 
300 of research is still in its infancy by considering the few human studies available. Future research 
301 should be targeted to identify the PPs and/or their metabolites eventually involved in the modulation 
302 of IP while demonstrating also their specific dose-dependent mechanisms of action. Meanwhile, in 
303 vivo studies should be performed to increase understanding of the diet-microbiota-intestinal 
304 permeability axis possibly through the development of well controlled dietary intervention studies. 
305 Finally, by considering the wide discussion in literature on IP evaluation, a further effort is needed to 
306 better define the reliability of the already available IP biomarkers and the potential exploitation of 
307 new and/or improved candidate biomarkers. 
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FIGURE CAPTION
Figure 1: Putative effects of polyphenols on IP at different physiological levels
Figure Caption: 1 – Intraluminal Level: Modulation of microbiota composition, endotoxin and/or 
short-chain fatty acid (SCFA) production, redox status, dietary component absorption and/or activity; 
2 – Intracellular Level: Regulation of expression of tight junction, adherens junction, gap junction 
and desmosome proteins, upregulation of kinases and nuclear factor erythroid 2-related factor 2 (Nrf-
2), dowregulation of nuclear factor kappa B (NF-kB) and toll-like receptor 4 (TLR4); 3 – Systemic 
Level:Maintenance of functional immune system and regulation of inflammatory processes (towards 
a reduced pro-inflammatory status).
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Table 1- Summary of the Main in Vitro Studies Highlighting the Mechanisms of Action of Polyphenol Compounds in the Modulation of Barrier 
Integrity and Function 
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Chuenkitiyanon et al., 
2010 64
ECV304 m)H2O2 Quercetin (10 µM) ↓n)p38 ZO-1, occludin ↑ ZO-1
↑ occludin
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D-(-)-quinic acids (10-50 
µM)
p-coumaric acids (10 
µM)
caffeic acids (20 µM)
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Noda et al., 2012 54 Caco-2 - Chrysin, daidzein, 
genistein, hesperetin, 
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Cao et al., 2013 56 Caco-2 IFN-γ, TNF-α Berberine (100 µM) ↓MLCK Occludin, claudin-







Carrasco-Pozo et al., 2013 
57












↓FD4 (no effect 
with rutin)
↑ ZO-1 after 
quercetin
↑ occludin after 
quercetin
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Wang et al., 2016 44 Caco-2 - Polyphenol-rich propolis 




ZO-1, occludin ↑ TEER
↑ occludin
↑ ZO-1
Azzini et al., 2016 45 Caco-2 - 3 different polyphenol-
rich extracts from 





Luescher et al., 2017 38 Caco-2 TNF-α Xanthohumol (chalcone; 





Cremonini et al., 2017 46 Caco-2 TNF-α
IFN-γ
cyanidin, delphinidin, 
malvidin, petunidin, or 
↓IKK and p65 
phosphorylation
TEER ↑TEER 
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chokeberry, black kernel 
rice, wild blueberry, 
bilberry, crowberry, 
domesticated blueberry, 
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TEER, v)IL-6, IL-8 ↑TEER
↓IL-6
↓IL-8
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↓ p-IkBα/IkBα








Vazquez-Olivo et al., 
2019 50
Caco-2 - 4 polyphenol-rich mango 
extracts (100 µg/mL)







Nunes et al., 2019 63 HT-29 TNF-α, 
IL-1, IFN-γ
Non-alcoholic 
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condensed tannin); 200, 
400 and 600 µg/mL
Note: a)TEER, trans-epithelial eletrical resistance; b)ZO-1, zonula occludens; c)IFN-γ, interferon gamma; d)STAT-1, signal transducer and activator 
of transcription 1; e)MAPK, mitogen-activated protein kinases; f)MLCK/MLC, myosin light-chain kinase; g)PKC, protein kinase C; h)TNF-α, tumor 
necrosis factor alpha; i)NF-kB, nuclear factor-kB; l)PI3K/Akt, phosphoinositide 3-kinase; m)H2O2, hydrogen peroxide; n)p38, p38 pathway; o)SP-1, 
specific protein transcription factor-1; p)JAM-A, junctional adhesion molecule-A; q)FD4, fluorescein isothiocyanate-labeled dextrans; r)ERK1/2, 
extracellular signal–regulated kinases; s)p-IKKα, IκB kinase α; t)JNK, c-Jun N-terminal kinases; u)IL-(6,8,10), interleukin-(6,8,10); v)AMPK, 5' AMP-
activated protein kinase; z)LPS, Lipopolysaccharide; x)NOX, nicotinamide adenine dinucleotide oxidase; y)FITC, fluorescein 
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Table 2- Summary of the Main Evidence from Animal Models Reporting the Effects of PPs and PP-rich Extracts in the Modulation of Barrier Integrity 
and Function     
Reference Animal 
model


































GSE: grape seed extract (0 
or 1% GSE)* 
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GSE: grape seed extract (0 
or 1% GSE)* 












raspberry extract (20 
mg/kg) 
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OEO: oregano essential 
oil (5 or 20 mg/kg BW)


















propolis extract (0.3% 
w/w)*








Bitzer et al 2016 73 Male CF-
1 mice
l)DSS treatment +
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DE (DDS + EGCG) + 








































↑GLP-2 (CE and 
HFE20)
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HF: high fat diet (60% 
total calories from fat); 











NG: naringin (30 mg/kg 
and 60 mg/kg)
C: None control diet 
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CLP + NG ↓ 
FITC-dextrane 
(dose-dependent)
Note: a)MLCK/MLC, myosin light-chain kinase; b)ZO-1, zonula occludens; c)IL, interleukin; d)NF-kB, nuclear factor-kB; e)AMPK, 5' AMP-activated 
protein kinase; f)MAPKs, mitogen-activated protein kinases; g)SOD, superoxide dismutase; h)GSH-Px, glutathione peroxidase; i)ERK1/2, extracellular 
signal–regulated kinases; l)DSS, dextran sulphate sodium; m)GLP-2, glucagon-like peptide-2; n)LAC/RHA, lactulose/rhamnose ratio; o)SUC/ERY, 
sucralose/erythritol ratio; p)JAM,  junctional adhesion molecule; q)p65, transcription factor p65; r)NOX1/NOX 4, NADPH oxidases; s)CLP, cecal ligation 
and puncture; t)TEM, transmission electron microscopy; u)FITC, fluorescein
*Data on polyphenol characterization not provided.
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Table 3- Summary of the Ongoing Human Studies Evaluating the Effect of PPs and PP-rich Food on Intestinal Permeability



















(BMI = 28-40 kg/m2)
 Fasting glucose < 126 
mg/dL
 Normotensive (blood 
pressure < 140/90 
mmHg)






Test group: green 
tea extract (GTE)-
rich confection
Placebo group: no 
green tea extract-
rich confection
Dose: daily (no 
information about 
the amount 
provided in term 
of polyphenols)





Mannitol Ratio, and 
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Calprotectin
Green tea polyphenol 
bioavailability
Effect of flavonoids 





 22 Male or female of 
any race or ethnicity 
between 18 to 49 years 
of age
 Competed in a road race 
or triathlon in past 12 
months
 Free of chronic disease 





Test group: a high 
flavonoid, sports 
nutrition recovery 
beverage will be 
prepared from 
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 Train at least 3 times 
per week, 1 hour at a 
time on average
 Willing to prepare and 
consume provided pre-
workout beverage daily
 Maintain weight (no 
more/less than 5 kg 
change)
 Willing to avoid 
consumption of high 
flavonoid 
foods/supplements, 
large dose vitamin and 
mineral supplements, 
and a)NSAIDs or other 






620 mg flavonoids 
per serving.




will be prepared 









Other variables related 
exercise performance
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Dose: 330 mL/ 
day 
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Prepared diet with 
diet high levels of 
dietary flavonoids 
(340 mg of 
flavonoids/1000 
Kcals) with a 
macronutrient 
composition of 
17% en from 
protein, 30% en 












chain fatty acids, 
eosinophil protein X,  
myeloperoxidase
Intestinal permeability 
by four sugar 
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Prepared diet with 
diet high levels of 
dietary flavonoids 
(10 mg of 
flavonoids/1000 
Kcals) with a 
macronutrient 
composition of 
17% en from 
protein, 30% en 
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Effect of a 
polyphenol-rich diet 





 60 healthy older 
subjects
 Age > 60 years old
 Intestinal Permeability 














8 weeks Primary outcome:
Zonulin serum levels
Secondary outcome: 
Total blood bacterial 
load 
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 Adequate nutritional 




 Good cognitive status 




assessed with validated 
tests (e.g. Barthel index 
- activities of daily 
living, Tinetti balance 
assessment)
juice, Renetta 
apple and purée, 
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mg of 
polyphenols) Metabolic and 
anthropometric 
markers
Note: a)NSAIDs, nonsteroidal anti-inflammatory drugs; b)TNF-α, tumor necrosis factor-alpha; c)IL-10, interleukin-10; d)BMI, body mass index; e)PCR, 
C-reactive protein; f)TNFr-2, tumor necrosis factor receptor-2; g)LPS-BP, lipopolysaccharide binding protein 
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Figure 1
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